Androderm

Orchitis, Puberty, Delayed, Gonadotrophin releasing hormone deficiency + 9 more

Treatment

17 FDA approvals

3 Active Studies for Androderm

What is Androderm

Testosterone

The Generic name of this drug

Treatment Summary

Testosterone is a hormone used to treat male sexual development issues. It works by binding to androgen receptors in the body, activating genes that cause the growth of male sex organs and other masculine traits. Testosterone was first discovered in 1935 through samples and synthetic creation.

Androderm

is the brand name

image of different drug pills on a surface

Androderm Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Androderm

Testosterone

1995

90

Approved as Treatment by the FDA

Testosterone, commonly known as Androderm, is approved by the FDA for 17 uses including Spermatic Cord Torsion and Puberty, Delayed .

Spermatic Cord Torsion

Helps manage Torsion of testis

Puberty, Delayed

Used to treat Puberty, Delayed in combination with Testosterone enanthate

Hypogonadism

Helps manage Hypergonadotropic Hypogonadism

Breast

Used to treat inoperable, metastatic Breast cancer in combination with Testosterone enanthate

Torsion of testis

Helps manage Torsion of testis

Hypothalamo-pituitary disorder

Helps manage Hypothalamo-pituitary disorder

Delayed Puberty

Used to treat Puberty, Delayed in combination with Testosterone enanthate

Orchitis

Helps manage Orchitis

Orchitis

Helps manage Orchitis

Hypergonadotropic Hypogonadism

Helps manage Hypergonadotropic Hypogonadism

Hypogonadotropic hypogonadism

Gonadotrophin releasing hormone deficiency

Helps manage Gonadotrophin releasing hormone deficiency

1 to 5 years post-menopausal

Used to treat 1 to 5 years post-menopausal in combination with Testosterone enanthate

Anorchia

Helps manage vanishing testis syndrome

Orchidectomy

Helps manage Orchidectomy

inoperable, metastatic Breast cancer

Used to treat inoperable, metastatic Breast cancer in combination with Testosterone enanthate

Hypogonadism

Helps manage Idiopathic Hypogonadotropic Hypogonadism

Effectiveness

How Androderm Affects Patients

Testosterone is a hormone that helps develop male sex organs and secondary sexual characteristics. Its effects vary from person to person, but generally last between 10-100 minutes. A typical adult man will have a testosterone level of 300-1000ng/dL, which is considered safe. It is important to note that children who come into contact with testosterone products may also experience its effects, so caution should be used when applying.

How Androderm works in the body

The androgen receptor helps the body develop masculine characteristics. It binds to testosterone and other hormones, which are carried into the nucleus of cells. Here, these hormones interact with DNA and other regulators to activate certain genes. This process is responsible for sexual development, including the growth of the prostate, penis, and scrotum. Testosterone also causes secondary sexual characteristics like facial and body hair, a deeper voice, and changes in muscle and fat distribution.

When to interrupt dosage

The measure of Androderm is dependent upon the indicated illness, such as Gonadotrophin releasing hormone deficiency, Orchidectomy and Orchitis. The dosage amount depends on the administration approach delineated in the table beneath.

Condition

Dosage

Administration

Breast

, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg

, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular

Orchitis

, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg

, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular

Puberty, Delayed

, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg

, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular

Gonadotrophin releasing hormone deficiency

, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg

, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular

1 to 5 years post-menopausal

, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg

, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular

Hypothalamo-pituitary disorder

, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg

, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular

Orchidectomy

, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg

, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular

Spermatic Cord Torsion

, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg

, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular

Hypogonadism

, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg

, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular

Hypogonadotropic hypogonadism

, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg

, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular

Anorchia

, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg

, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular

Hypogonadism

, 0.01 mg/mg, 0.05 mg/mg, 75.0 mg, 100.0 mg/mL, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 200.0 mg/mL, 30.0 mg/mL, 30.0 mg, 100.0 mg, 200.0 mg, 37.5 mg, 25.0 mg, 50.0 mg, 87.5 mg, 40.0 mg, 1.0 %, 4.5 %, 0.03 mg/hour, 5.5 mg, 0.1 mg/mg, 250.0 mg/mL, 0.0125 mg/mg, 12.5 mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 0.00162 mg/mg, 0.02025 mg/mg, 0.0405 mg/mg, 30.0 mg/pump actuation, 12.5 mg/pump actuation, 60.0 mg

, Transdermal, Gel - Transdermal, Gel, Injection, solution - Intramuscular, Intramuscular, Gel - Topical, Topical, Subcutaneous, Pellet - Subcutaneous, Pellet, Solution, Solution - Topical, Tablet, Buccal, Pellet - Oral, Oral, Capsule, Capsule - Oral, Gel - Nasal, Patch - Transdermal, Nasal, Gel, metered - Topical, Gel, metered, Patch, Solution - Transdermal, Gel, metered - Nasal, Gel, metered - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable, Pellet, implantable - Parenteral, Parenteral, Injection - Intramuscular, Tablet - Buccal, Suspension, Suspension - Intramuscular

Warnings

Androderm has two contraindications. It should not be employed for the conditions enumerated in the table below.

Androderm Contraindications

Condition

Risk Level

Notes

suspected pregnancy

Do Not Combine

Breast Cancer

Do Not Combine

There are 20 known major drug interactions with Androderm.

Common Androderm Drug Interactions

Drug Name

Risk Level

Description

Abemaciclib

Major

The metabolism of Abemaciclib can be increased when combined with Testosterone.

Acalabrutinib

Major

The metabolism of Acalabrutinib can be increased when combined with Testosterone.

Alectinib

Major

The metabolism of Alectinib can be increased when combined with Testosterone.

Aminophylline

Major

The metabolism of Aminophylline can be increased when combined with Testosterone.

Astemizole

Major

The metabolism of Astemizole can be increased when combined with Testosterone.

Androderm Toxicity & Overdose Risk

There is limited information about overdosing on topical testosterone products. If an injectable product is overdosed, a stroke may occur. To treat an overdose, stop taking the testosterone product, clean the skin with soap and water if the product was topical, and provide supporting treatments.

image of a doctor in a lab doing drug, clinical research

Androderm Novel Uses: Which Conditions Have a Clinical Trial Featuring Androderm?

10 active investigations are assessing the potential of Androderm for alleviating Orchitis, Testicular Torsion and Hypothalamo-pituitary Dysfunction.

Condition

Clinical Trials

Trial Phases

Hypothalamo-pituitary disorder

0 Actively Recruiting

1 to 5 years post-menopausal

0 Actively Recruiting

Hypogonadism

0 Actively Recruiting

Orchitis

0 Actively Recruiting

Spermatic Cord Torsion

0 Actively Recruiting

Orchidectomy

0 Actively Recruiting

Breast

0 Actively Recruiting

Hypogonadotropic hypogonadism

0 Actively Recruiting

Puberty, Delayed

0 Actively Recruiting

Gonadotrophin releasing hormone deficiency

0 Actively Recruiting

Anorchia

0 Actively Recruiting

Hypogonadism

3 Actively Recruiting

Phase 2

Androderm Reviews: What are patients saying about Androderm?

5

Patient Review

9/27/2012

Androderm for Deficiency of a Substance that Promotes Masculinization

I've only been taking this for a week, and I'm already seeing better performance in the gym. My recovery time is shorter, and my libido has increased. I would gladly pay out of pocket to keep taking this medication because it's improved my quality of life so much.

3.7

Patient Review

5/16/2014

Androderm for Deficiency of Luteinizing Hormone-Releasing Hormone

This treatment really helped me out. My drive increased and it almost always cured my ED. I had more energy, which was great for getting things done around the house. The only downside is that it can make you a bit more aggressive; but overall, I'm really happy with this product!

3

Patient Review

7/6/2016

Androderm for Deficiency of a Substance that Promotes Masculinization

The 4mg patch has really helped me with my energy levels and muscle shaping.

2.7

Patient Review

3/11/2017

Androderm for Deficient Activity of the Testis

I'll update this review after I've used the product for a longer period of time. For now, I want to leave a note about the company. I reached out with some questions but they were unhelpful because all they do is sell the product. This seems like very basic information that should be readily available to customers.

2.7

Patient Review

4/23/2012

Androderm for Deficiency of a Substance that Promotes Masculinization

My husband started using the 4mg Androderm patches and noticed enlarged NON-tender lymph nodes in his neck. Has anyone had this experience?? He has a history of Hodgkin's lymphoma so he's seen his oncologist & has a biopsy scheduled. I'd rather this be some sort of rare reaction to the patches verses a Hodgkin's relapse.

2.7

Patient Review

1/29/2021

Androderm for Deficient Activity of the Testis

I'm 73 and think I might have age-related hormone deficiencies. In the past, I've used testosterone shots, gel, and now patches. The shots were uncomfortable, the gel was messy, and the patches are leaving itchy red welts that last weeks--on top of being very expensive. Not happy with any of these options.

2.3

Patient Review

9/4/2012

Androderm for Deficiency of a Substance that Promotes Masculinization

I was on this medication for six weeks. It gave me more energy at first, but then stopped working and started causing deep burning pain in my arms and shoulders. Has anyone else experienced this side effect?

2.3

Patient Review

1/23/2015

Androderm for Deficiency of Luteinizing Hormone-Releasing Hormone

The Androderm patch unfortunately gave me prostatitis, insomnia, and a general feeling of malaise.

2

Patient Review

9/24/2014

Androderm for Deficient Activity of the Testis

My Total T level at start was 234 My free was also very low. After 6 weeks on 4mg Androderm patch my levels were again checked. Total Testosterone NINETY SIX !!!! Free almost non existent!! WTF?? Doctor started me injections immediately. This stuff made me worse? How can it DROP you that far?

1.7

Patient Review

12/8/2012

Androderm for Deficiency of a Substance that Promotes Masculinization

This medication didn't provide any benefits for me. A waste of time and money.

1.3

Patient Review

3/31/2013

Androderm for Deficiency of a Substance that Promotes Masculinization

Unfortunately, my testosterone levels dropped even lower after using the androderm patch for just one month.

1

Patient Review

8/26/2020

Androderm for Deficient Activity of the Testis

I took Androderm for 31 days and had no change in my testosterone levels. Consequently, I would not recommend this treatment to anyone.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about androderm

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How long does it take Androderm to work?

"It takes three weeks for the effects of this medication to start showing on sexual interest, and these effects will stay the same for six weeks with no chance of increasing. Changes in erections and ejaculations could take up to six months to show. The effects of this medication on quality of life should start to show within three to four weeks, but the maximum benefits will take longer."

Answered by AI

Is Androderm safe?

"Androderm can also cause less serious side effects, such as skin reactions where the patch is applied.

The testosterone patch Androderm can cause life-threatening blood clots in your legs or lungs. Symptoms of a clot in the legs include leg pain, swelling, or redness. Symptoms of a clot in the lungs include difficulty breathing or chest pain. Androderm can also cause less serious side effects, such as skin reactions where the patch is applied."

Answered by AI

What is Androderm used for?

"This medication is used to supplement the testosterone levels in men who are not able to produce enough on their own. The medication is absorbed through the skin and enters the bloodstream, where it helps the body to reach normal testosterone levels."

Answered by AI

Do you need a prescription for Androderm?

"ANDRODERM is a prescription medicine that contains testosterone and is used to treat adult males who have low or no testosterone due to certain medical conditions. Your healthcare provider will test your blood for testosterone before you start and while you are taking ANDRODERM."

Answered by AI

Clinical Trials for Androderm

Image of ReproNovo Investigational Site in Garden City, United States.

Leflutrozole for Hypogonadotropic Hypogonadism

18 - 49
Male
Garden City, NY

The goal of this clinical trial is to evaluate three doses of the drug leflutrozole on improvement of semen quality in men with hypogonadotropic hypogonadism, a condition that affects hormone levels and fertility. It will also study the safety of leflutrozole. The main questions it aims to answer are: * Does leflutrozole improve semen quality? * What medical problems do participants experience when taking leflutrozole? Researchers will compare leflutrozole to a placebo (a look-alike substance that contains no drug). Participants will: * Take leflutrozole or a placebo orally once a week for 16 weeks. * Visit the clinic every 4 weeks for checkups and tests. * Provide semen samples to measure changes in semen quality. * Have their blood tested to measure hormone levels and ensure safety. * Be monitored for any side effects.

Phase 2
Recruiting

ReproNovo Investigational Site (+2 Sites)

Medical Director

ReproNovo Aps